Phase II Study of ASP3550 in Patients With Prostate Cancer

Clinical trial NCT00568516 · COMPLETED

Trial details

NCT number: NCT00568516
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2007-10-01
Primary completion: 2009-10-01
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.